Catalyst Wire Dossier Catalyst Wire Dossier

Evinacumab

evinacumab · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Evinacumab, covering 2018-06-25 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

See pricing